Annual Cash & Cash Equivalents:
$99.59M-$3.23M(-3.14%)Summary
- As of today, VRDN annual cash & cash equivalents is $99.59 million, with the most recent change of -$3.23 million (-3.14%) on December 31, 2024.
- During the last 3 years, VRDN annual cash & cash equivalents has risen by +$57.30 million (+135.45%).
- VRDN annual cash & cash equivalents is now -35.98% below its all-time high of $155.58 million, reached on December 31, 2022.
Performance
VRDN Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$563.36M-$73.28M(-11.51%)Summary
- As of today, VRDN quarterly cash & cash equivalents is $563.36 million, with the most recent change of -$73.28 million (-11.51%) on June 30, 2025.
- Over the past year, VRDN quarterly cash & cash equivalents has dropped by -$8.01 million (-1.40%).
- VRDN quarterly cash & cash equivalents is now -25.21% below its all-time high of $753.24 million, reached on September 30, 2024.
Performance
VRDN Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
VRDN Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -3.1% | -1.4% |
| 3Y3 Years | +135.4% | +249.5% |
| 5Y5 Years | +300.9% | +1742.1% |
VRDN Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -36.0% | +135.4% | -25.2% | +80.0% |
| 5Y | 5-Year | -36.0% | +300.9% | -25.2% | +1772.9% |
| All-Time | All-Time | -36.0% | >+9999.0% | -25.2% | >+9999.0% |
VRDN Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $563.36M(-11.5%) |
| Mar 2025 | - | $636.63M(-11.3%) |
| Dec 2024 | $99.59M(-3.1%) | $717.58M(-4.7%) |
| Sep 2024 | - | $753.24M(+31.8%) |
| Jun 2024 | - | $571.37M(-6.8%) |
| Mar 2024 | - | $613.19M(+28.5%) |
| Dec 2023 | $102.83M(-33.9%) | $477.37M(+52.5%) |
| Sep 2023 | - | $313.01M(-6.4%) |
| Jun 2023 | - | $334.29M(-10.6%) |
| Mar 2023 | - | $373.86M(-11.9%) |
| Dec 2022 | $155.58M(+267.8%) | $424.55M(-1.6%) |
| Sep 2022 | - | $431.32M(+167.6%) |
| Jun 2022 | - | $161.21M(-8.1%) |
| Mar 2022 | - | $175.43M(-10.9%) |
| Dec 2021 | $42.30M | $196.97M(-7.9%) |
| Sep 2021 | - | $213.81M(+95.6%) |
| Jun 2021 | - | $109.30M(-6.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $117.10M(-8.3%) |
| Dec 2020 | $45.90M(+84.7%) | $127.64M(+324.3%) |
| Sep 2020 | - | $30.08M(-1.6%) |
| Jun 2020 | - | $30.58M(-15.3%) |
| Mar 2020 | - | $36.10M(-42.2%) |
| Dec 2019 | $24.85M(-23.8%) | - |
| Dec 2018 | $32.61M(-31.3%) | $62.48M(+31.7%) |
| Dec 2017 | $47.44M(+1320.0%) | $47.44M(+114.6%) |
| Dec 2016 | $3.34M(-69.2%) | $22.10M(+104.1%) |
| Dec 2015 | $10.83M(+111.6%) | $10.83M(-10.7%) |
| Sep 2015 | - | $12.12M(+16.0%) |
| Jun 2015 | - | $10.45M(-21.3%) |
| Mar 2015 | - | $13.27M(+159.2%) |
| Dec 2014 | $5.12M(+2349.3%) | $5.12M(-19.9%) |
| Sep 2014 | - | $6.39M(-17.0%) |
| Jun 2014 | - | $7.70M(+3582.4%) |
| Dec 2013 | $209.00K(+85.8%) | $209.00K |
| Dec 2012 | $112.50K | - |
FAQ
- What is Viridian Therapeutics, Inc. annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. annual cash & cash equivalents year-on-year change?
- What is Viridian Therapeutics, Inc. quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?
What is Viridian Therapeutics, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of VRDN is $99.59M
What is the all-time high annual cash & cash equivalents for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high annual cash & cash equivalents is $155.58M
What is Viridian Therapeutics, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, VRDN annual cash & cash equivalents has changed by -$3.23M (-3.14%)
What is Viridian Therapeutics, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of VRDN is $563.36M
What is the all-time high quarterly cash & cash equivalents for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high quarterly cash & cash equivalents is $753.24M
What is Viridian Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, VRDN quarterly cash & cash equivalents has changed by -$8.01M (-1.40%)